You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

15 search results for: biomarkers

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma
Podcast

ADVENT On Air | The Road Ahead: Achieving Remission for ​Patients With Asthma

Pulmonology
Join Professors Klaus Rabe and Ian Pavord as they discuss the importance of on-treatment clinical remission as a goal in asthma management.
View more
ADVENT On Air | Role of Type 2 Inflammation in COPD
Podcast

ADVENT On Air | Role of Type 2 Inflammation in COPD

Pulmonology
Drs Stephanie Christenson and Jean Bourbeau explore the role of type 2 inflammation in Chronic Obstructive Pulmonary Disease (COPD).
View more
FeNO as a Biomarker for Type 2 Asthma
expert video

FeNO as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Eugene Bleecker presents the utility of FeNO as a biomarker of type 2 inflammation and its role in the disease burden of asthma.
View more
IgE as a Biomarker for Type 2 Asthma
expert video

IgE as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Jonathan Corren describes the diagnostic, predictive, and prognostic role of IgE as a biomarker of type 2 inflammation in asthma.
View more
How Can FeNO Measurement Improve Severe Asthma Management?
expert video

How Can FeNO Measurement Improve Severe Asthma Management?

Pulmonology
Join Dr. Miguel Lanz as he explains the clinical utility of FeNO as a biomarker of severe asthma.
View more
Eosinophils as a Biomarker for Type 2 Asthma
expert video

Eosinophils as a Biomarker for Type 2 Asthma

Pulmonology
Dr. Elliot Israel presents the utility of eosinophils as a biomarker of type 2 inflammation and their role in the disease burden of asthma.
View more
What is the Role of FeNO as an Asthma Biomarker?
expert video

What is the Role of FeNO as an Asthma Biomarker?

Pulmonology
Prof. Klaus Rabe and Dr. Michael Wechsler explore the utility of FeNO as a biomarker in asthma.
View more
How Can FeNO Support the Management of Pediatric Asthma?
expert video

How Can FeNO Support the Management of Pediatric Asthma?

Pulmonology
Dr. Michael Blaiss discusses the importance of measuring FeNO in pediatric asthma patients.
View more
FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients
Infographic

FeNO: A Biomarker of Type 2 Inflammation in Pediatric Asthma Patients

Pulmonology
Learn about the role of FeNO as a noninvasive test to identify type 2 inflammation in pediatric patients with asthma.
View more
Why Is It Important to Assess Lung Function in Pediatric Asthma
interactivity

Why Is It Important to Assess Lung Function in Pediatric Asthma

Pulmonology
Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma
View more
Adult Asthma Interactive Patient Cases
interactivity

Adult Asthma Interactive Patient Cases

Pulmonology
Explore 3 hypothetical patient cases using guideline-based checklists for assessment and diagnosis of type 2 inflammation in adult asthma.
View more
On-Treatment Clinical Remission in Asthma Patients Case Tool
interactivity

On-Treatment Clinical Remission in Asthma Patients Case Tool

Pulmonology
Review a severe asthma patient case to learn more about assessing asthma control and on-treatment clinical remission.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-US-2305040 v3.0-P Exp. Date: 11/24/2025

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: United StatesChange country/region